Arcturus Gets $220M More
Monday, November 23, 2020
Arcturus Therapeutics has partnered with Israel in a deal reportedly worth hundreds of millions of dollars to begin clinical trials on humans in Singapore for its COVID-19 vaccine.
Arcturus Therapeutics, has announced positive interim clinical study results from its ongoing Phase 1/2 study of ARCT-021, its vaccine candidate for COVID-19...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know